Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
2024 · Nature · 280 citations
https://doi.org/10.1038/s41586-024-07205-6
J
Jennifer E. Klomp
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
151
Papers
2.4K
Citations
20
h-index
22
i10-index
Jennifer E. Klomp is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Advanced Breast Cancer Therapies & Pancreatic and Hepatic Oncology Research & Colorectal Cancer Treatments and Studies. The author has an h-index of 20, co-authored 129 publications.
ORCID: 0000-0003-1781-648XPapers by this author
worksDefining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
2024 · Science · 91 citations
https://doi.org/10.1126/science.adk0775
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
2021 · Journal of Biological Chemistry · 28 citations
https://doi.org/10.1016/j.jbc.2021.101335
Dissecting the Role of c-Src in the Regulation of Adherens Junctions using Engineered Kinases
2017 · Figshare · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat